K. Maes
发表
K. Breckpot,
K. Vanderkerken,
E. Menu,
2018,
Oncoimmunology.
K. Vanderkerken,
E. Van Valckenborgh,
P. Agarwal,
2015,
Oncotarget.
G. Requirand,
T. Rème,
B. Klein,
2018,
British Journal of Cancer.
X. Leleu,
K. Vanderkerken,
E. Van Valckenborgh,
2016,
Cancer letters.
K. Vanderkerken,
E. Menu,
E. De Bruyne,
2019,
Cancers.
B. Klein,
J. Moreaux,
D. Hose,
2014,
Oncotarget.
Catharina Olsen,
R. Schots,
I. Vande broek,
2022,
Cancers.
J. Moreaux,
D. Hose,
C. Heirman,
2018,
Cancer research.
K. Vanderkerken,
E. Van Valckenborgh,
E. Menu,
2015,
Oncotarget.
F. Prósper,
X. Agirre,
V. Basso,
2022,
Frontiers in Immunology.
J. Moreaux,
D. Hose,
S. Verhulst,
2022,
Frontiers in Cell and Developmental Biology.
J. Moreaux,
D. Hose,
R. King,
2015,
Oncotarget.
J. Tavernier,
S. van Calenbergh,
K. Venken,
2017,
Leukemia.
L. Boon,
K. Venken,
X. Leleu,
2017,
Haematologica.
R. Schots,
K. Vanderkerken,
H. de Raeve,
2018,
Blood Cancer Journal.
K. Breckpot,
K. Vanderkerken,
E. Menu,
2022,
Frontiers in Immunology.
J. Swinnen,
R. Schots,
J. Dehairs,
2019,
Cancers.
J. Moreaux,
J. V. Van Ginderachter,
A. Kassambara,
2019,
Cancer letters.
K. Vanderkerken,
E. Menu,
E. De Bruyne,
2018,
Front. Oncol..
J. Fraczek,
V. Rogiers,
K. Vanderkerken,
2013
.
K. Vanderkerken,
E. Menu,
E. De Bruyne,
2017,
Oncotarget.
R. Schots,
J. V. Van Ginderachter,
K. Breckpot,
2017,
The Journal of pathology.
A. de Becker,
I. Van Riet,
K. Maes,
2022,
Frontiers in Bioengineering and Biotechnology.
R. Schots,
K. Vanderkerken,
E. Van Valckenborgh,
2016,
Oncotarget.
Elizabeta Nemeth,
Tomas Ganz,
Karin Vanderkerken,
2010,
Blood.
K. Vanderkerken,
E. Van Valckenborgh,
E. Menu,
2015,
Oncotarget.
K. Vanderkerken,
E. Van Valckenborgh,
E. Menu,
2013,
Cancers.
F. Offner,
K. Vanderkerken,
E. Menu,
2019,
Front. Genet..
J. Moreaux,
K. Vanderkerken,
H. de Raeve,
2019,
Blood Cancer Journal.
F. Prósper,
X. Agirre,
A. Mondino,
2021,
Frontiers in Immunology.
S. McClue,
K. Vanderkerken,
E. Van Valckenborgh,
2014,
Oncotarget.
H. Johnsen,
M. Nyegaard,
C. Conover,
2016,
Oncotarget.
K. Breckpot,
K. Maes,
2019,
Front. Cell Dev. Biol..
J. Moreaux,
D. Hose,
A. Kassambara,
2017,
Cancer Immunology Research.
D. Hose,
K. Breckpot,
M. Törngren,
2023,
Journal for ImmunoTherapy of Cancer.
E. Menu,
E. De Bruyne,
K. De Veirman,
2018,
International journal of molecular sciences.
R. Schots,
K. Vanderkerken,
H. de Raeve,
2018,
Blood Cancer Journal.
G. Requirand,
J. Moreaux,
N. Robert,
2021,
Blood advances.
J. Moreaux,
F. Offner,
M. Spaargaren,
2019,
British Journal of Cancer.
D. Lambrechts,
B. Boeckx,
K. Vanderkerken,
2018,
Scientific Reports.
M. Bertrand,
S. Magez,
Afshin Samali,
2017,
Oncotarget.
B. Miller,
Q. Lecocq,
V. Caveliers,
2020,
Molecular pharmaceutics.
W. Staels,
J. De Schepper,
C. Ernst,
2023,
Journal of Medical Case Reports.
J. Moreaux,
F. Offner,
M. Spaargaren,
2019,
British Journal of Cancer.
The IGF-1 receptor inhibitor picropodophyllin potentiates the anti-myeloma activity of a BH3-mimetic
O. Larsson,
H. Johnsen,
M. Nyegaard,
2014,
Oncotarget.
D. Lambrechts,
B. Boeckx,
K. Vanderkerken,
2018,
Scientific Reports.
J. Moreaux,
D. Hose,
C. Heirman,
2018,
Cancer research.